INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.72B / 19S · 11 late91 trades$22.97M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09SISarowitz Steven I2B / 34S36 trades$21.18M
  10. 10CMCannon-Brookes Michael35B / 0S35 trades$11.72M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 189 insiders$1.02M
  3. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  4. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  5. SELLMGNIMAGNITE, INC.Nov 5 – Nov 198 insiders$2.81M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

74,187 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
1
RL
Reynoso Jamie L.CEO, Medicare Advantage
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$5,318
2,102 sh
Jan 7, 2026
Page 1569 of 1855
← PrevNext →
Jan 7, 2026
traded Jan 7, 2026
+0d
SEC Form 4

Evidence

1
AA
Ashish AroraDirector, Chief Executive Officer, 10% Owner
CRCTCricut, Inc.
Open-market sale · 10b5-1 plan
SELL$103K
20.8K sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

1
KS
Kazmaier Gerrit SPresident, Prod. and Tech.
WDAYWorkday, Inc.
Tax withholding · 10b5-1 plan
F$499K
2,427 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

1
AA
Ashish AroraDirector, Chief Executive Officer, 10% Owner
CRCTCricut, Inc.
Open-market sale · 10b5-1 plan
SELL$101K
20.8K sh
Jan 6, 2026Jan 7, 2026
traded Jan 6, 2026
+1dSEC Form 4

Evidence

1
AA
Ashish AroraDirector, Chief Executive Officer, 10% Owner
CRCTCricut, Inc.
Open-market sale · 10b5-1 plan
SELL$103K
20.8K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

1
RM
Rizik MatthewDirector
RKTRocket Companies, Inc.
Open-market sale · 10b5-1 plan
SELL$52K
2,500 sh
Jan 6, 2026Jan 7, 2026
traded Jan 6, 2026
+1dSEC Form 4

Evidence

0
Tenev VladimirDirector, Chief Executive Officer
HOODRobinhood Markets, Inc.
Derivative conversion · 10b5-1 plan
C—
375.0K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
OO
Okupe OluyemiChief Financial Officer
HIMSHims & Hers Health, Inc.
Option exercise · 10b5-1 plan
M—
2,178 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
102.8K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
HT
Holme TimothyCHIEF TECHNOLOGY OFFICER
QSQuantumScape Corp
Derivative conversion · 10b5-1 plan
C—
44.9K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
OO
Okupe OluyemiChief Financial Officer
HIMSHims & Hers Health, Inc.
Option exercise · 10b5-1 plan
M$11K
2,178 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
8,335 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
DS
Desmond SeanDirector, CEO & President
NCNOnCino, Inc.
Option exercise · 10b5-1 plan
M—
7,331 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
GC
Gibson ChristopherDirector
RXRXRECURSION PHARMACEUTICALS, INC.
Derivative conversion · 10b5-1 plan
C—
60.0K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
GC
Gibson ChristopherDirector
RXRXRECURSION PHARMACEUTICALS, INC.
Gift · 10b5-1 plan
G—
20.0K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
OO
Okupe OluyemiChief Financial Officer
HIMSHims & Hers Health, Inc.
Option exercise · 10b5-1 plan
M$44K
3,808 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
Armstrong BrianDirector, Chairman and CEO, 10% Owner
COINCoinbase Global, Inc.
Option exercise · 10b5-1 plan
M—
40.0K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
102.8K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
HK
Holleran KevinDirector, President and CEO
HAYWHayward Holdings, Inc.
Option exercise · 10b5-1 plan
M—
52.4K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
GC
Gibson ChristopherDirector
RXRXRECURSION PHARMACEUTICALS, INC.
Derivative conversion · 10b5-1 plan
C—
60.0K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
AL
Alpern Paul LVP and General Counsel
AIPArteris, Inc.
Option exercise · 10b5-1 plan
M—
2,500 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
DS
Desmond SeanDirector, CEO & President
NCNOnCino, Inc.
Option exercise · 10b5-1 plan
M$37K
7,331 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
8,335 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
Tenev VladimirDirector, Chief Executive Officer
HOODRobinhood Markets, Inc.
Derivative conversion · 10b5-1 plan
C—
375.0K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
3,000 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
HT
Holme TimothyCHIEF TECHNOLOGY OFFICER
QSQuantumScape Corp
Derivative conversion · 10b5-1 plan
C—
166.4K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
3,000 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
AL
Alpern Paul LVP and General Counsel
AIPArteris, Inc.
Option exercise · 10b5-1 plan
M$23K
2,500 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
Xu TonyDirector, CHIEF EXECUTIVE OFFICER, 10% Owner
DASHDoorDash, Inc.
Option exercise · 10b5-1 plan
M—
16.7K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
HT
Holme TimothyCHIEF TECHNOLOGY OFFICER
QSQuantumScape Corp
Derivative conversion · 10b5-1 plan
C—
166.4K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
HT
Holme TimothyCHIEF TECHNOLOGY OFFICER
QSQuantumScape Corp
Derivative conversion · 10b5-1 plan
C—
44.9K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
Armstrong BrianDirector, Chairman and CEO, 10% Owner
COINCoinbase Global, Inc.
Option exercise · 10b5-1 plan
M$748K
40.0K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence